Nicotine and tobacco as substances of abuse in children and adolescents

Pediatrics

Volumn 139, Issue 1, 2017, Pages

  Siqueira, Lorena M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMFEBUTAMONE; CIGARETTE SMOKE; NICOTINE; NICOTINE GUM; NICOTINE LOZENGE; NICOTINE PATCH; NICOTINE VACCINE; NICOTINIC RECEPTOR; VARENICLINE; PASSIVE SMOKING;

ABSORPTION; ACUTE TOXICITY; ADOLESCENCE; ADOLESCENT; ADVERSE OUTCOME; AGE; ARTICLE; CENTRAL NERVOUS SYSTEM; CHILD; CHILDHOOD; CRAVING; ELECTRONIC CIGARETTE; GENOTYPE; HUMAN; METABOLISM; NEUROBIOLOGY; NEUROPHYSIOLOGY; NICOTINE REPLACEMENT THERAPY; NONHUMAN; PALATABILITY; PERIPHERAL NERVOUS SYSTEM; PHARMACOGENETICS; PRENATAL EXPOSURE; PRIORITY JOURNAL; RACE DIFFERENCE; RISK FACTOR; SEX DIFFERENCE; SMOKING; SMOKING CESSATION; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; WITHDRAWAL SYNDROME; ADVERSE EFFECTS; BRAIN; CROSS-SECTIONAL STUDY; DRUG EFFECTS; NERVOUS SYSTEM; PASSIVE SMOKING; PREVENTION AND CONTROL; STATISTICS AND NUMERICAL DATA; TOBACCO; TOBACCO USE DISORDER; UNITED STATES; UPREGULATION;

ADOLESCENT; BRAIN; CHILD; CROSS-SECTIONAL STUDIES; ELECTRONIC CIGARETTES; HUMANS; NERVOUS SYSTEM; RECEPTORS, NICOTINIC; SMOKING; TOBACCO PRODUCTS; TOBACCO SMOKE POLLUTION; TOBACCO USE DISORDER; UNITED STATES; UP-REGULATION;

EID: 85009079600     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2016-3436     Document Type: Article

References (98)

1. Centers for Disease Control and Prevention. Smoking and tobacco use: disease and death. Available at: www.cdc.gov/tobacco/data-statistics/fact-sheets/fast-facts/. Accessed June 10, 2016
2. Centers for Disease Control and Prevention. Notes from the field: electronic cigarette use among middle and high school students-United States, 2011-2012. MMWR Morb Mortal Wkly Rep. 2013;62(35):729-730
3. Johnston LD, O'Malley PM, Miech RA, Bachman JG, Schulenberg JE. Monitoring the Future: National Survey Results on Drug Use: 1975-2014. Overview, Key Findings on Adolescent Drug Use. 2015. Available at: www.monitoringthefutu re.org/pubs/monographs/mtf-overview2014.pdf. Accessed June 10, 2016
4. Walley SC, Jenssen BP; Section on Tobacco Control. Electronic nicotine delivery systems. Pediatrics. 2015;136(5):1018-1026
5. US Department of Health and Human Services. The Health Consequences of Smoking: Cardiovascular Disease: A Report of the Surgeon General. Washington, DC: US Department of Health and Human Services, Public Health Service, Office of Smoking and Health; 1983. DHHS Publication PHS-84-50204
6. Bristow LR. Tobacco, history, and the AMA. Lancet. 1995;346(8976):704-705
7. Siegmund B, Leitner E, Pfannhauser W. Determination of the nicotine content of various edible nightshades (Solanaceae) and their products and estimation of the associated dietary nicotine intake. J Agric Food Chem. 1999;47(8):3113-3120
8. Benowitz NL, Hall SM, Herning RI, Jacob P III, Jones RT, Osman AL. Smokers of low-yield cigarettes do not consume less nicotine. N Engl J Med. 1983;309(3):139-142
9. World Health Organization. International Classification of Diseases. Available at: www.who. int/classifications/icd/en/. Accessed June 10, 2016
10. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 5th ed. Arlington, VA: American Psychiatric Association Publishing; 2013
11. US Department of Health and Human Services. Preventing Tobacco Use Among Youth and Young Adults: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2012
12. Campaign for Tobacco-Free Kids. The path to tobacco addiction starts at very young ages. Available at: www.tobaccofreekids.org/research/factsheets/pdf/0127.pdf. Accessed June 10, 2016
13. Chassin L, Presson CC, Sherman SJ, Edwards DA. The natural history of cigarette smoking: predicting young-adult smoking outcomes from adolescent smoking patterns. Health Psychol. 1990;9(6):701-716
14. US Department of Health and Human Services. The Health Consequences of Smoking: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health; 2014
15. Tyas SL, Pederson LL. Psychosocial factors related to adolescent smoking: A critical review of the literature. Tob Control. 1998;7(4):409-420
16. Shiffman S, Paty J. Smoking patterns and dependence: contrasting chippers and heavy smokers. J Abnorm Psychol. 2006;115(3):509-523
17. DiFranza JR, Wellman RJ. A sensitization-homeostasis model of nicotine craving, withdrawal, and tolerance: integrating the clinical and basic science literature. Nicotine Tob Res. 2005;7(1):9-26
18. DiFranza JR, Savageau JA, Rigotti NA, et al. Development of symptoms of tobacco dependence in youths: 30 month follow up data from the DANDY study. Tob Control. 2002;11(3):228-235
19. Scragg R, Wellman RJ, Laugesen M, DiFranza JR. Diminished autonomy over tobacco can appear with the first cigarettes. Addict Behav. 2008;33(5):689-698
20. DiFranza JR, Savageau JA, Fletcher K, et al. Symptoms of tobacco dependence after brief intermittent use: The Development and Assessment of Nicotine Dependence in Youth-2 Study. Arch Pediatr Adolesc Med. 2007;161(7):704-710
21. Doubeni CA, Reed G, Difranza JR. Early course of nicotine dependence in adolescent smokers. Pediatrics. 2010;125(6):1127-1133
22. DiFranza JR, Ursprung WW, Biller L. The developmental sequence of tobacco withdrawal symptoms of wanting, craving and needing. Pharmacol Biochem Behav. 2012;100(3):494-497
23. Maisto SA, Galizio M, Connors GJ, eds. Drug Use and Abuse. 4th ed. Belmont, CA: Wadsworth/Thompson Learning; 2004
24. Karan LD, Dani JA, Benowitz NL. The pharmacology of nicotine dependence. In: Ries RK, Miller SC, Fiellin DA, Saitz R, eds. Principles of Addiction Medicine. 3rd ed. Washington, DC: American Society of Addiction Medicine; 2003:225-248
25. Kreslake JM, Wayne GF, Connolly GN. The menthol smoker: tobacco industry research on consumer sensory perception of menthol cigarettes and its role in smoking behavior. Nicotine Tob Res. 2008;10(4):705-715
26. Anderson SJ. Marketing of menthol cigarettes and consumer perceptions: A review of tobacco industry documents. Tob Control. 2011;20(suppl 2):ii20-ii28
27. Anderson SJ. Menthol cigarettes and smoking cessation behaviour: A review of tobacco industry documents. Tob Control. 2011;20(suppl 2):ii49-ii56
28. Tierney PA, Karpinski CD, Brown JE, Luo W, Pankow JF. Flavour chemicals in electronic cigarette fluids. Tob Control. 2016;25(e1):e10-e15
29. Huang W, DiFranza JR, Kennedy DN, et al. Progressive levels of physical dependence to tobacco coincide with changes in the anterior cingulum bundle microstructure. PLoS One. 2013;8(7):e67837
30. Adinoff B. Neurobiologic processes in drug reward and addiction. Harv Rev Psychiatry. 2004;12(6):305-320
31. Weinstein SM, Mermelstein R, Shiffman S, Flay B. Mood variability and cigarette smoking escalation among adolescents. Psychol Addict Behav. 2008;22(4):504-513
32. Hendrickson LM, Guildford MJ, Tapper AR. Neuronal nicotinic acetylcholine receptors: common molecular substrates of nicotine and alcohol dependence. Front Psychiatry. 2013;4:1-16
33. Kandel ER, Kandel DB. Shattuck Lecture: A molecular basis for nicotine as a gateway drug. N Engl J Med. 2014;371(10):932-943
34. Jones-Burton C, Vessal G, Brown J, Dowling TC, Fink JC. Urinary cotinine as an objective measure of cigarette smoking in chronic kidney disease. Nephrol Dial Transplant. 2007;22(7):1950-1954
35. Benowitz NL, Kuyt F, Jacob P III, Jones RT, Osman AL. Cotinine disposition and effects. Clin Pharmacol Ther. 1983;34(5):604-611
36. Hukkanen J, Jacob P III, Benowitz NL. Metabolism and disposition kinetics of nicotine. Pharmacol Rev. 2005;57(1):79-115
37. Evans WE, Johnson JA. Pharmacogenomics: The inherited basis for interindividual differences in drug response. Annu Rev Genomics Hum Genet. 2001;2:9-39
38. Mwenifumbo JC, Tyndale RF. Genetic variability in CYP2A6 and the pharmacokinetics of nicotine. Pharmacogenomics. 2007;8(10):1385-1402
39. Ho MK, Tyndale RF. Overview of the pharmacogenomics of cigarette smoking. Pharmacogenomics J. 2007;7(2):81-98
40. Tobacco and Genetics Consortium. Genome-wide meta-analyses identify multiple loci associated with smoking behavior. Nat Genet. 2010;42(5):441-447
41. Thorgeirsson TE, Gudbjartsson DF, Surakka I, et al; ENGAGE Consortium. Sequence variants at CHRNB3-CHRNA6 and CYP2A6 affect smoking behavior. Nat Genet. 2010;42(5):448-453
42. Schlaepfer IR, Hoft NR, Ehringer MA. The genetic components of alcohol and nicotine co-addiction: from genes to behavior. Curr Drug Abuse Rev. 2008;1(2):124-134
43. Schoedel KA, Hoffmann EB, Rao Y, Sellers EM, Tyndale RF. Ethnic variation in CYP2A6 and association of genetically slow nicotine metabolism and smoking in adult Caucasians. Pharmacogenetics. 2004;14(9):615-626
44. Piper ME, Cook JW, Schlam TR, et al. Gender, race, and education differences in abstinence rates among participants in two randomized smoking cessation trials. Nicotine Tob Res. 2010;12(6):647-657
45. Benowitz NL, Lessov-Schlaggar CN, Swan GE, Jacob P III. Female sex and oral contraceptive use accelerate nicotine metabolism. Clin Pharmacol Ther. 2006;79(5):480-488
46. Rubinstein ML, Shiffman S, Rait MA, Benowitz NL. Race, gender, and nicotine metabolism in adolescent smokers. Nicotine Tob Res. 2013;15(7):1311-1315
47. Berlin I, Gasior MJ, Moolchan ET. Sexbased and hormonal contraception effects on the metabolism of nicotine among adolescent tobaccodependent smokers. Nicotine Tob Res. 2007;9(4):493-498
48. Rubinstein ML, Shiffman S, Moscicki AB, Rait MA, Sen S, Benowitz NL. Nicotine metabolism and addiction among adolescent smokers. Addiction. 2013;108(2):406-412
49. Collins S, Rollason TP, Young LS, Woodman CB. Cigarette smoking is an independent risk factor for cervical intraepithelial neoplasia in young women: A longitudinal study. Eur J Cancer. 2010;46(2):405-411
50. Tweed JO, Hsia SH, Lutfy K, Friedman TC. The endocrine effects of nicotine and cigarette smoke. Trends Endocrinol Metab. 2012;23(7):334-342
51. Buchmann AF, Laucht M, Schmid B, Wiedemann K, Mann K, Zimmermann US. Cigarette craving increases after a psychosocial stress test and is related to cortisol stress response but not to dependence scores in daily smokers. J Psychopharmacol. 2010;24(2):247-255
52. Henningfield JE, Miyasato K, Jasinski DR. Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther. 1985;234(1):1-12
53. Thomas GA, Rhodes J, Green JT. Inflammatory bowel disease and smoking-a review. Am J Gastroenterol. 1998;93(2):144-149
54. Boyko EJ, Koepsell TD, Perera DR, Inui TS. Risk of ulcerative colitis among former and current cigarette smokers. N Engl J Med. 1987;316(12):707-710
55. Birrenbach T, Böcker U. Inflammatory bowel disease and smoking: A review of epidemiology, pathophysiology, and therapeutic implications. Inflamm Bowel Dis. 2004;10(6):848-859
56. Wang H, Yu M, Ochani M, et al. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature. 2003;421(6921):384-388
57. Jain G, Jaimes EA. Nicotine signaling and progression of chronic kidney disease in smokers. Biochem Pharmacol. 2013;86(8):1215-1223
58. Black HR, Zeevi GR, Silten RM, Walker Smith GJ. Effect of heavy cigarette smoking on renal and myocardial arterioles. Nephron. 1983;34(3):173-179
59. Yoon V, Maalouf NM, Sakhaee K. The effects of smoking on bone metabolism. Osteoporos Int. 2012;23(8):2081-2092
60. Jo YH, Talmage DA, Role LW. Nicotinic receptor-mediated effects on appetite and food intake. J Neurobiol. 2002;53(4):618-632
61. US Department of Health and Human Services. Women and Smoking: A Report of the Surgeon General. Rockville, MD: US Department of Health and Human Services, Office of Smoking and Health; 2001
62. Perkins KA. Smoking cessation in women: special considerations. CNS Drugs. 2001;15(5):391-411
63. Koopmann A, Bez J, Lemenager T, et al. Effects of cigarette smoking on plasma concentration of the appetiteregulating peptide ghrelin. Ann Nutr Metab. 2015;66(2-3):155-161
64. Bruin JE, Gerstein HC, Holloway AC. Long-term consequences of fetal and neonatal nicotine exposure: A critical review. Toxicol Sci. 2010;116(2):364-374
65. Fried PA, Watkinson B, Gray R. Differential effects on cognitive functioning in 13-to 16-year-olds prenatally exposed to cigarettes and marihuana. Neurotoxicol Teratol. 2003;25(4):427-436
66. Goldschmidt L, Richardson GA, Willford J, Day NL. Prenatal marijuana exposure and intelligence test performance at age 6. J Am Acad Child Adolesc Psychiatry. 2008; 47(3):254-263
67. Morris CV, DiNieri JA, Szutorisz H, Hurd YL. Molecular mechanisms of maternal cannabis and cigarette use on human neurodevelopment. Eur J Neurosci. 2011;34(10):1574-1583
68. Browne CJ, Sharma N, Waters KA, Machaalani R. The effects of nicotine on the alpha-7 and beta-2 nicotinic acetycholine receptor subunits in the developing piglet brainstem. Int J Dev Neurosci. 2010;28(1):1-7
69. Sekizawa S, Joad JP, Pinkerton KE, Bonham AC. Secondhand smoke exposure alters K+ channel function and intrinsic cell excitability in a subset of second-order airway neurons in the nucleus tractus solitarius of young guinea pigs. Eur J Neurosci. 2010;31(4):673-684
70. St-John WM, Leiter JC. Maternal nicotine depresses eupneic ventilation of neonatal rats. Neurosci Lett. 1999;267(3):206-208
71. Eugenín J, Otárola M, Bravo E, et al. Prenatal to early postnatal nicotine exposure impairs central chemoreception and modifies breathing pattern in mouse neonates: A probable link to sudden infant death syndrome. J Neurosci. 2008;28(51):13907-13917
72. Fewell JE, Smith FG, Ng VK. Prenatal exposure to nicotine impairs protective responses of rat pups to hypoxia in an age-dependent manner. Respir Physiol. 2001;127(1):61-73
73. Akil H, Watson SJ, Young E, Lewis ME, Khachaturian H, Walker JM. Endogenous opioids: biology and function. Annu Rev Neurosci. 1984;7:223-255
74. Duncan JR, Paterson DS, Kinney HC. The development of nicotinic receptors in the human medulla oblongata: inter-relationship with the serotonergic system. Auton Neurosci. 2008;144(1-2):61-75
75. Paine SM, Jacques TS, Sebire NJ. Review: neuropathological features of unexplained sudden unexpected death in infancy: current evidence and controversies. Neuropathol Appl Neurobiol. 2014;40(4):364-384
76. Falk L, Nordberg A, Seiger A, Kjaeldgaard A, Hellström-Lindahl E. Smoking during early pregnancy affects the expression pattern of both nicotinic and muscarinic acetylcholine receptors in human first trimester brainstem and cerebellum. Neuroscience. 2005;132(2):389-397
77. Matturri L, Ottaviani G, Alfonsi G, Crippa M, Rossi L, Lavezzi AM. Study of the brainstem, particularly the arcuate nucleus, in sudden infant death syndrome (SIDS) and sudden intrauterine unexplained death (SIUD). Am J Forensic Med Pathol. 2004;25(1):44-48
78. American Academy of Pediatrics Committee on Fetus and Newborn. SIDS and other sleep-related infant deaths: evidence base for updated 2016 recommendations for a safe sleeping environment. Pediatrics. 2016;138(5):e20162940
79. Appleton S. Frequency and outcomes of accidental ingestion of tobacco products in young children. Regul Toxicol Pharmacol. 2011;61(2):210-214
80. Sisselman SG, Mofenson HC, Caraccio TR. Childhood poisonings from ingestion of cigarettes. Lancet. 1996;347(8995):200-201
81. Chatham-Stephens K, Law R, Taylor E, et al; Centers for Disease Control and Prevention. Notes from the field: calls to poison centers for exposures to electronic cigarettes-United States, September 2010-February 2014. MMWR Morb Mortal Wkly Rep. 2014;63(13):292-293
82. Mohney G. First child's death from liquid nicotine reported as 'vaping' gains popularity. ABC News. December 12, 2014. Available at: http://abcnews. go.com/Health/childs-death-liquidnicotine-reported-vaping-gainspopularity/story? id= 27563788. Accessed November 18, 2016
83. Mayer B. How much nicotine kills a human? Tracing back the generally accepted lethal dose to dubious selfexperiments in the nineteenth century. Arch Toxicol. 2014;88(1):5-7
84. Soghian S. Nicotine. In: Nelson LS, Lewin NA, Howland MA, Hoffman RS, Goldfrank LR, Flomenbaum NE, eds. Goldfrank's Toxicologic Emergencies. 9th ed. New York, NY: McGraw-Hill; 2011:1185-1189
85. Kim JW, Baum CR. Liquid nicotine toxicity. Pediatr Emerg Care. 2015;31(7):517-521; quiz: 522-524
86. Bassett RA, Osterhoudt K, Brabazon T. Nicotine poisoning in an infant. N Engl J Med. 2014;370(23):2249-2250
87. Agency for Healthcare Research and Quality. US Preventive Services Task Force Guides to Clinical Preventive Services. 2nd ed. Rockville, MD: US Public Health Service; 1996. Available at: www.ncbi. nlm. nih.gov/books/NBK61778/. Accessed June 10, 2016
88. Chen J, Millar WJ. Age of smoking initiation: implications for quitting. Health Rep. 1998;9(4):39-46
89. Fiore MC, Jaén CR, Baker TB, et al Treating Tobacco Use and Dependence: 2008 Update [Clinical Practice Guideline]. Rockville, MD: US Department of Health and Human Services, Public Health Service; May 2008
90. American College of Chest Physicians. Tobacco Dependence Treatment Toolkit. 3rd ed. Available at: http://tobaccodependence . chestnet.org. Accessed June 10, 2016
91. Farber HJ, Walley SC, Groner JA, Nelson KE; Section on Tobacco Control. Clinical practice policy to protect children from tobacco, nicotine, and tobacco smoke. Pediatrics. 2015;136(5):1008-1017
92. Dutra LM, Glantz SA. Electronic cigarettes and conventional cigarette use among U.S. adolescents: A cross-sectional study. JAMA Pediatr. 2014;168(7):610-617
93. Grana RA, Popova L, Ling PM. A longitudinal analysis of electronic cigarette use and smoking cessation. JAMA Intern Med. 2014;174(5): 812-813
94. Pentel PR, LeSage MG. New directions in nicotine vaccine design and use. Adv Pharmacol. 2014;69:553-580
95. Tonstad S, Heggen E, Giljam H, et al. Niccine®, a nicotine vaccine, for relapse prevention: A phase II, randomized, placebo-controlled, multicenter clinical trial. Nicotine Tob Res. 2013;15(9):1492-1501
96. Hartmann-Boyce J, Cahill K, Hatsukami D, Cornuz J. Nicotine vaccines for smoking cessation. Cochrane Database Syst Rev. 2012; (8):CD007072
97. Farber HJ, Groner J, Walley S, Nelson K; Section on Tobacco Control. Protecting children from tobacco, nicotine and tobacco smoke. Pediatrics. 2015;136(5):e1439-e1467
98. Sussman S, Sun P, Dent CW. A meta-analysis of teen cigarette smoking cessation. Health Psychol. 2006;25(5):549-557